4-Anilinoquinazoline Derivatives with Epidermal Growth Factor Receptor Inhibitor Activity

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 12, 2016-12 ,pp. : 1652-1664

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal growth factor receptor family tyrosine kinases as signal integrators and therapeutic targets

By Barnes C.J.  

Cancer and Metastasis Reviews, Vol. 22, Iss. 4, 2003-12 ,pp. : 301-307

Springer Publishing Company

Access to resources Recommend Favorite

Primary and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Update

By Ayoola Ayodele   Barochia Amit   Belani Kiran   Belani Chandra P.  

Cancer Investigation, Vol. 30, Iss. 5, 2012-05 ,pp. : 433-446

Informa Healthcare

Access to resources Recommend Favorite

Selective inhibition of the epidermal growth factor receptor tyrosine kinase by BIBX1382BS and the improvement of growth delay, but not local control, after fractionated irradiation in human FaDu squamous cell carcinoma in the nude mouse

By Baumann M.   Krause M.   Zips D.   Eicheler W.   Dörfler A.   Ahrens J.   Petersen C.   Brüchner K.   Hilberg F.  

International Journal of Radiation Biology, Vol. 79, Iss. 7, 2003-07 ,pp. : 547-559

Informa Healthcare

Access to resources Recommend Favorite

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

By Carrera S.   Buque A.   Azkona E.   Aresti U.   Calvo B.   Sancho A.   Arruti M.   Nuño M.   Rubio I.   Lobera A.   Lopez C.   Vivanco G.  

Clinical and Translational Oncology, Vol. 16, Iss. 4, 2014-04 ,pp. : 339-350

Springer Publishing Company

Access to resources Recommend Favorite